Yüklüyor......
Safety of biologics in inflammatory bowel disease patients with COVID-19
BACKGROUND: Patients with Inflammatory bowel disease (IBD) remain highly concerned that either their disease or medications—namely, biologics—may increase the risk of severe coronavirus-2019 (COVID-19). We aimed to assess the safety of biologics in Inflammatory bowel disease (IBD) patients with COVI...
Kaydedildi:
| Yayımlandı: | Int J Colorectal Dis |
|---|---|
| Asıl Yazarlar: | , , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Springer Berlin Heidelberg
2021
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8205311/ https://ncbi.nlm.nih.gov/pubmed/34131784 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00384-021-03977-9 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|